Toronto’s stock market extended its rally during Tuesday’s mid-trading session, fueled by a broad-based advance in the technology and commercial services sectors. The S&P/TSX Composite Index rose 0.7% to 33257.00, supported largely by a significant rating upgrade for e-commerce leader Shopify.
Open Text shares surged in Toronto trading after the Canadian enterprise software giant announced a $200 million expansion to its share repurchase program. The move brings the total aggregate value of the fiscal 2026 buyback initiative to $500 million, reflecting a significant ramp-up in the company's capital return strategy.
McDonald’s is set to report its fourth-quarter results on Wednesday, with analysts forecasting a rise in both profit and revenue as the fast-food giant’s pivot to value meals draws cost-conscious diners back to the Golden Arches.
Dakota Gold shares fell more than 9% on Monday after the company priced a public offering of 12.3 million shares, a move expected to generate at least $75 million in gross proceeds. The capital raise follows a period of significant growth for the firm, which has seen its market valuation nearly double over the past year.
Moderna shares climbed 6.7% on Tuesday following a five-year agreement with the Mexican government to secure a domestic supply of respiratory vaccines. The deal includes a technology transfer to local drugmaker Liomont, enabling the domestic production of mRNA COVID-19 shots to bolster the country's pandemic readiness.
Cosmetics giant Estée Lauder has filed a federal lawsuit against Walmart, alleging the retail titan sold counterfeit versions of high-end fragrances and skincare products through its e-commerce platform. The complaint, lodged in a California court, accuses Walmart of trademark infringement and false designation of origin involving several of the world’s most recognizable prestige brands.
Vestis shares jumped Tuesday after the workplace supplies provider reported adjusted earnings that exceeded Wall Street expectations and projected steady margin growth through aggressive cost-cutting. Despite a slight revenue miss, investors rallied behind the company’s forecast of 5% sequential quarterly growth in adjusted EBITDA.
U.S. commercial crude oil stockpiles likely contracted for a third consecutive week as refineries maintained robust operations, according to a Wall Street Journal survey of analysts and traders. The anticipated drawdown comes ahead of official government data scheduled for release on Wednesday.
Crude oil and refined product futures edged lower during Tuesday midday trading as markets corrected from a two-session rally, though persistent geopolitical friction between Washington and Tehran provided a firm floor for prices. Despite the retreat, supply risks remain elevated following a U.S. government warning for commercial vessels to navigate cautiously through critical Middle Eastern shipping lanes.
Quest Diagnostics shares surged to an all-time high on Tuesday after the laboratory giant issued a full-year forecast that eclipsed Wall Street estimates, driven by resilient demand for preventative health screenings and diagnostic services.
Five workers were transported to the hospital on Monday night following a fire at Valero Energy Corp.’s refinery in Ardmore, Oklahoma. The company confirmed the blaze was extinguished shortly after it began at the 90,000 barrel-per-day facility, though the specific cause of the incident and the severity of the injuries remain under investigation.
Hasbro has finalized a multi-year licensing agreement with Warner Bros. Discovery Global Consumer Products, positioning the toy giant as the primary global licensee for the Harry Potter franchise. The deal, which officially begins in 2027, coincides with the highly anticipated debut of the HBO Original Harry Potter television series.
Sutro Biopharma shares surged 10% after the clinical-stage biotech company priced a $110 million underwritten offering of 7.9 million shares. The deal, priced at $13.98 per share, attracted a mix of new and existing institutional investors to support the firm’s oncology development pipeline.
Canadian Prime Minister Mark Carney is attempting to de-escalate a burgeoning diplomatic rift with the United States after President Trump demanded a 50% ownership stake in the yet-to-open Gordie Howe International Bridge. Despite Canada financing the construction of the 1.5-mile corridor, Trump has threatened to block its 2026 opening unless Ottawa provides compensation and addresses a suite of trade grievances.
Amsterdam-based AI cloud provider Nebius announced on Tuesday its acquisition of Tavily, a specialized search engine built for artificial intelligence agents. The deal aims to integrate Tavily’s real-time web navigation and fact-verification capabilities into the Nebius platform, enabling developers to build and deploy sophisticated autonomous systems.
Xylem shares tumbled on Tuesday after the water technology provider issued a full-year outlook that trailed Wall Street estimates. Despite a solid performance in the recent quarter, the company’s aggressive focus on streamlining its portfolio and exiting low-margin markets is tempering near-term growth expectations.
TotalEnergies SE has released its latest transparency update regarding its share capital and voting rights, reporting a total of 2,206,585,543 shares in circulation as of January 31, 2026.
Goodyear Tire & Rubber shares plunged on Tuesday after the company reported fourth-quarter adjusted earnings that failed to meet analyst projections. Despite a modest beat on top-line revenue, the tire manufacturer's bottom line suffered from what leadership described as a non-linear recovery in a volatile industry landscape.
InterDigital has initiated a global legal offensive against Chinese electronics giants Hisense and TCL, alleging the unauthorized use of video compression and high-dynamic-range (HDR) technologies. The lawsuits, filed across multiple jurisdictions including Germany, Brazil, and India, target intellectual property held within InterDigital’s joint licensing program with Sony.
Williams reported a significant jump in fourth-quarter profit on Tuesday, driven by the successful rollout of pipeline transmission and offshore projects throughout 2025. While net income climbed to $733 million, the energy infrastructure giant narrowly missed analyst expectations for adjusted earnings as it prepares for a new phase of power innovation.
The J.M. Smucker Co. is overhauling its executive suite, eliminating the position of chief operating officer and redistributing key responsibilities across its top leadership. Effective Feb. 9, the reorganization sees CEO Mark Smucker reclaim the title of president as the food giant pivots toward a more integrated management model and launches a search for its first AI-focused chief technology officer.
EssilorLuxottica is set to report its 2025 fiscal results this Wednesday, with investors looking to see if the group's blockbuster partnership with Meta can outpace persistent production bottlenecks. While the Franco-Italian eyewear giant is expected to post a significant revenue increase to over 28 billion euros, the spotlight remains on the logistical and legal friction surrounding its flagship AI-powered smartglasses.
European Wax Center shares skyrocketed Tuesday after the company announced an agreement to be taken private by its largest shareholder, General Atlantic. The all-cash transaction values the waxing services provider at approximately $330 million.
Incyte reported a significant jump in fourth-quarter profit as revenue soared to $1.51 billion, driven by robust demand for its flagship cancer treatment Jakafi and the skin-cream therapy Opzelura. While the biotechnology firm comfortably beat top-line expectations, adjusted earnings fell slightly short of Wall Street estimates.
European Wax Center has entered a definitive agreement to be acquired by its largest shareholder, General Atlantic, in an all-cash transaction valued at approximately $330 million. The deal marks a strategic exit from the public markets for the waxing services giant as it seeks stability following a volatile year on the Nasdaq.
Shares of Amentum Holdings slid nearly 10% in premarket trading Tuesday after the government services contractor reported a sharper-than-expected revenue decline for its fiscal first quarter, offsetting an earnings beat driven by aggressive cost-cutting measures.
S&P Global shares dropped nearly 9% in premarket trading after the financial intelligence firm issued long-term earnings guidance that trailed Wall Street estimates, overshadowing a solid fourth-quarter performance driven by its core ratings and indices businesses.
Fiserv Inc. reported fourth-quarter results that surpassed Wall Street expectations on Tuesday, as a surge in retail payment processing countered a slowdown in its core banking technology business. While net income dipped compared to the previous year, the Milwaukee-based fintech giant posted $5.28 billion in revenue, signaling resilience despite cooling demand from traditional financial institutions.
Nektar Therapeutics shares jumped 13% in premarket trading Tuesday after the biotechnology firm reported positive results from a mid-stage study of its atopic dermatitis treatment. The Phase 2b Rezolve-AD trial demonstrated that its novel biologic, rezpegaldesleukin, successfully maintained skin clearance in a majority of patients over a 36-week maintenance period.
Credo Technology Group shares jumped 17% in pre-market trading Tuesday after the connectivity solutions provider significantly raised its third-quarter revenue guidance, signaling a massive acceleration in growth compared to previous estimates.
